
Dr. Benjamin Jon Golas explains that surgery, chemotherapy and radiation form the foundation of curative-intent treatment for patients with pancreas cancer.

Dr. Benjamin Jon Golas explains that surgery, chemotherapy and radiation form the foundation of curative-intent treatment for patients with pancreas cancer.

Dr. Nadine A. Jackson explains how relatively simple interventions may help close gaps in access to genomics-driven trials across gastrointestinal cancers.

Joe McDonough shares what message he hopes families hear when first facing a cancer diagnosis.

Dr. Ian Flinn explains how Lunsumio VELO works, offering an outpatient immunotherapy option with accelerated FDA approval.

Oya Gilbert blends hip-hop and advocacy to raise awareness about myeloma, engage patients, and address broader health issues in underserved communities.

Tukysa may be a patient-friendly option as a first line maintenance treatment for HER2-positive breast cancer, as Dr. Erika Hamilton explained.

Dr. Thejus Jayakrishnan discussed how patients and physicians weigh treatment options in later-line metastatic colorectal cancer.

Mayra Andujar-Delgado shares her 10-year myelofibrosis journey and how 2025 Blood Cancer Hero Dr. Faseeh Khaja empowered her and her husband.

Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma.

Dr. William A. Hall discusses overtreatment in gastrointestinal cancer care and how AI-driven response assessment is shaping personalized treatment.

Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.

Dave Coulier sat down for an interview with CURE to discuss his recent tongue cancer diagnosis and his treatment journey.

Dr. Vinayak Venkataraman sat down for an interview with CURE to discuss the evolving treatment of gastrointestinal stromal tumors.

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy played in her care.

Prostate cancer survivors Ronald Wakefield and Ernie Strauss sat down for an interview with CURE.

Dave Coulier, who has become a vocal advocate during his cancer journeys, has launched a digital wellness platform, AwearMarket.

Wendy Brooks, a survivor of extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, highlight the role of self-advocacy.

Dan, a pancreatic cancer survivor and advocate, shared insights on participating in clinical trials and the importance of self-advocacy.

Joe McDonough sat down for an interview with CURE to share his family’s story and the inspiration behind the B+ Foundation.

Mayra Andujar-Delgado shares how Dr. Faseeh Khaja’s compassionate care and unique bedside manner earned him recognition at the 2025 Blood Cancer Heroes.

Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.

Cancer survivor and author Bill Potts was recently honored as a Blood Cancer Hero.

CURE spoke with an expert about why a support system is crucial for patients with lung cancer.

CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.

Jace Yawnick explained why a support system is essential for patients with cancer.

Dr. Vikram Gorantla explains to CURE that staying healthy and managing side effects helps patients with brain metastases remain on therapy.

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

Dan describes how early self-advocacy, second opinions and trial research helped him pursue experimental treatments that led to remission from stage 4 pancreatic cancer.